vs
STANDARD BIOTOOLS INC.（LAB）与USCB FINANCIAL HOLDINGS, INC.（USCB）财务数据对比。点击上方公司名可切换其他公司
USCB FINANCIAL HOLDINGS, INC.的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$22.2M vs $19.6M），USCB FINANCIAL HOLDINGS, INC.净利率更高（6.1% vs -177.4%，领先183.5%），USCB FINANCIAL HOLDINGS, INC.同比增速更快（14.7% vs -11.5%），USCB FINANCIAL HOLDINGS, INC.自由现金流更多（$42.5M vs $-23.1M），过去两年USCB FINANCIAL HOLDINGS, INC.的营收复合增速更高（12.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
USCB金融控股公司是一家总部位于美国的银行控股企业，提供全面的零售与商业银行业务，包括存款产品、个人及企业贷款、财富管理及数字银行服务，主要服务个人消费者、中小微企业及当地企业客户，主打个性化服务与社区导向的金融支持。
LAB vs USCB — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $22.2M |
| 净利润 | $-34.7M | $1.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 14.7% |
| 净利率 | -177.4% | 6.1% |
| 营收同比 | -11.5% | 14.7% |
| 净利润同比 | -28.8% | -80.3% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $22.2M | ||
| Q3 25 | $19.6M | $25.0M | ||
| Q2 25 | $21.8M | $24.4M | ||
| Q1 25 | $40.8M | $22.8M | ||
| Q4 24 | — | $23.0M | ||
| Q3 24 | $22.1M | $21.5M | ||
| Q2 24 | $22.5M | $20.5M | ||
| Q1 24 | $45.5M | $17.6M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-34.7M | $8.9M | ||
| Q2 25 | $-33.5M | $8.1M | ||
| Q1 25 | $-26.0M | $7.7M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | $-26.9M | $6.9M | ||
| Q2 24 | $-45.7M | $6.2M | ||
| Q1 24 | $-32.2M | $4.6M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 14.7% | ||
| Q3 25 | -168.5% | 47.3% | ||
| Q2 25 | -118.1% | 44.0% | ||
| Q1 25 | -80.8% | 44.2% | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | -120.9% | 42.5% | ||
| Q2 24 | -134.5% | 39.8% | ||
| Q1 24 | -132.2% | 34.3% |
| Q4 25 | — | 6.1% | ||
| Q3 25 | -177.4% | 35.8% | ||
| Q2 25 | -153.7% | 33.4% | ||
| Q1 25 | -63.8% | 33.5% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | -122.0% | 32.3% | ||
| Q2 24 | -203.3% | 30.3% | ||
| Q1 24 | -70.6% | 26.2% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | $0.45 | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | $0.35 | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $38.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $217.2M |
| 总资产 | $539.6M | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $38.5M | ||
| Q3 25 | $129.4M | $56.8M | ||
| Q2 25 | $158.6M | $54.8M | ||
| Q1 25 | $150.9M | $98.0M | ||
| Q4 24 | — | $77.0M | ||
| Q3 24 | $210.6M | $38.5M | ||
| Q2 24 | $269.8M | $77.3M | ||
| Q1 24 | $287.1M | $126.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $217.2M | ||
| Q3 25 | $399.7M | $209.1M | ||
| Q2 25 | $424.5M | $231.6M | ||
| Q1 25 | $454.6M | $225.1M | ||
| Q4 24 | — | $215.4M | ||
| Q3 24 | $489.3M | $213.9M | ||
| Q2 24 | $510.3M | $201.0M | ||
| Q1 24 | $577.3M | $195.0M |
| Q4 25 | — | $2.8B | ||
| Q3 25 | $539.6M | $2.8B | ||
| Q2 25 | $557.0M | $2.7B | ||
| Q1 25 | $579.6M | $2.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | $681.5M | $2.5B | ||
| Q2 24 | $708.7M | $2.5B | ||
| Q1 24 | $777.7M | $2.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $42.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $42.5M |
| 自由现金流率自由现金流/营收 | -118.1% | 191.4% |
| 资本支出强度资本支出/营收 | 4.5% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 31.40× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $95.1M |
8季度趋势，按日历期对齐
| Q4 25 | — | $42.8M | ||
| Q3 25 | $-22.2M | $20.1M | ||
| Q2 25 | $-20.7M | $18.0M | ||
| Q1 25 | $-30.3M | $14.6M | ||
| Q4 24 | — | $34.8M | ||
| Q3 24 | $-27.9M | $11.3M | ||
| Q2 24 | $-39.0M | $18.3M | ||
| Q1 24 | $-62.5M | $8.1M |
| Q4 25 | — | $42.5M | ||
| Q3 25 | $-23.1M | $20.0M | ||
| Q2 25 | $-22.6M | $18.0M | ||
| Q1 25 | $-35.3M | $14.6M | ||
| Q4 24 | — | $34.5M | ||
| Q3 24 | $-30.1M | $11.2M | ||
| Q2 24 | $-41.0M | $18.2M | ||
| Q1 24 | $-63.3M | $8.0M |
| Q4 25 | — | 191.4% | ||
| Q3 25 | -118.1% | 80.3% | ||
| Q2 25 | -103.6% | 73.7% | ||
| Q1 25 | -86.6% | 63.9% | ||
| Q4 24 | — | 150.2% | ||
| Q3 24 | -136.4% | 52.2% | ||
| Q2 24 | -182.2% | 88.8% | ||
| Q1 24 | -138.9% | 45.4% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 4.5% | 0.5% | ||
| Q2 25 | 8.7% | 0.2% | ||
| Q1 25 | 12.4% | 0.2% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | 10.2% | 0.4% | ||
| Q2 24 | 8.6% | 0.4% | ||
| Q1 24 | 1.7% | 0.5% |
| Q4 25 | — | 31.40× | ||
| Q3 25 | — | 2.25× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 2.95× | ||
| Q1 24 | — | 1.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
USCB
暂无分部数据
